Skip to main content
Bright Eye Hospital Group Co., Ltd. logo

Bright Eye Hospital Group Co., Ltd. — Investor Relations & Filings

Ticker · 301239 ISIN · CNE100005GX3 Shenzhen Stock Exchange Human health and social work activities
Open in API
Filings indexed 511 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301239

About Bright Eye Hospital Group Co., Ltd.

https://www.purui.cn

Bright Eye Hospital Group Co., Ltd. is a specialized medical institution group focused on providing comprehensive ophthalmic services. The organization operates an extensive network of eye hospitals and clinics, offering a wide range of clinical treatments including cataract surgery, refractive error correction, glaucoma management, and vitreoretinal disease therapy. Key services encompass advanced laser vision correction, intraocular lens implantation, and pediatric optometry focused on myopia prevention and control. The group integrates clinical care with medical research and professional education, utilizing high-precision diagnostic technology and surgical equipment. Its service model emphasizes standardized clinical pathways and patient-centered care to address diverse visual health requirements across various age groups.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份质押的公告
Regulatory Filings Classification · 80% confidence The document is an official announcement of the company’s controlling shareholder pledging part of its existing shareholding as collateral. It is neither an issuance of new shares nor a dividend notice, management change, annual/interim report, nor investor presentation. It is a required regulatory disclosure under exchange rules on shareholder pledge activities—i.e., a miscellaneous regulatory filing that does not fall into any more specific category. Hence, it is classified as a Regulatory Filing (RNS).
2026-05-29 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the 2025 Annual General Meeting (“年度股东会”) resolutions and detailed voting results on each proposal, including attendance, vote tallies, and legal opinions. It reports the outcome of shareholder votes and percentage of votes for each resolution. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-22 Chinese
北京国枫律师事务所关于普瑞眼科医院集团股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 85% confidence The document is a formal legal opinion letter from an external law firm on the legality of convening, holding, and voting procedures at the company’s 2025 Annual General Meeting. It is not the AGM presentation materials themselves (AGM-R), nor a standalone financial report, proxy statement, or dividends notice. Rather, it is a compliance/legal document filed in connection with the AGM. Under the taxonomy, such external counsel opinions on corporate governance matters fall under Regulatory Filings (RNS) as a catch-all for compliance documents.
2026-05-22 Chinese
关于控股股东部分股份质押的公告
Regulatory Filings Classification · 85% confidence The document is an exchange announcement by 普瑞眼科医院集团股份有限公司 concerning the pledge of shares by its controlling shareholder. It provides detailed tables on the number of shares pledged, pledge dates, and related parties. This is not a report of a share buyback or issuance by the company itself (POS), nor is it a change in shareholding percentage crossing thresholds (MRQ). It is also not a financial report, management report, or any other specialized category. Therefore, it falls under general regulatory disclosure filings. As it does not fit any more specific category, it is classified as a Regulatory Filing (RNS).
2026-05-21 Chinese
国泰海通证券股份有限公司关于普瑞眼科医院集团股份有限公司首次公开发行股票之保荐总结报告书
Regulatory Filings Classification · 80% confidence The document is a Chinese “保荐总结报告书” prepared by the sponsoring securities firm summarizing its due diligence, continuous supervision and regulatory compliance work in connection with an IPO and listing. It is neither an IPO announcement by the issuer nor a financial report (annual or interim), nor a typical earnings release, management or governance report. It is a regulatory compliance report required by the China Securities Regulatory Commission, fitting the broad “Regulatory Filings” category as a catch-all for such miscellaneous regulatory compliance documents.
2026-05-14 Chinese
国泰海通证券股份有限公司关于普瑞眼科医院集团股份有限公司2025年年度持续督导跟踪报告
Regulatory Filings Classification · 85% confidence The document is a ‘持续督导跟踪报告’ prepared by the sponsor (Guotai Hightong Securities) under Shenzhen Stock Exchange rules, detailing ongoing supervision activities post-IPO (disclosure reviews, governance oversight, site visits, special opinions, regulatory measures, etc.). It is not an annual or interim financial report, earnings release, management change notice, voting results announcement, or any other highly specific category. Instead, it is a compliance/reporting submission to the exchange, which falls under the ‘General regulatory announcements, compliance documents, and miscellaneous filings’ category.
2026-05-14 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.